1. Share Prices

  2. Ondine Biomedical Inc. (OBI)

12.25p-0.75 (-5.77%)05 Nov 2025, 16:49
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Ondine Biomedical Inc. Fundamentals

Company NameOndine Biomedical Inc.Last Updated2025-11-05
IndustryBiotechnologySectorHealthcare
Shares in Issue518.367 mMarket Cap£63.50 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-0.07 CADEPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0131Debt Equity Ratio0
Asset Equity Ratio1.8645Cash Equity Ratio1.4202
Quick Ratio1.7292Current Ratio2.05
Price To Book Value18.0832ROCE0

Ondine Biomedical Inc. Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Ondine Biomedical Inc. Company Financials

Assets202420232022
Tangible Assets597,000.00 CAD949,000.00 CAD1.40 m CAD
Intangible Assets000
Investments000
Total Fixed Assets634,000.00 CAD984,000.00 CAD1.44 m CAD
Stocks1.27 m CAD1.07 m CAD1.29 m CAD
Debtors513,000.00 CAD326,000.00 CAD182,000.00 CAD
Cash & Equivalents9.77 m CAD2.98 m CAD13.13 m CAD
Other Assets000
Total Assets12.82 m CAD5.73 m CAD16.57 m CAD
Liabilities202420232022
Creditors within 1 year5.95 m CAD3.49 m CAD3.91 m CAD
Creditors after 1 year0159,000.00 CAD1.02 m CAD
Other Liabilities000
Total Liabilities5.95 m CAD3.65 m CAD4.92 m CAD
Net assets6.88 m CAD2.08 m CAD11.64 m CAD
Equity202420232022
Called up share capital262.60 m CAD239.65 m CAD235.04 m CAD
Share Premium000
Profit / Loss-19.10 m CAD-14.41 m CAD-19.37 m CAD
Other Equity6.88 m CAD2.08 m CAD11.64 m CAD
Preference & Minorities000
Total Capital Employed6.88 m CAD2.08 m CAD11.64 m CAD
Ratios202420232022
Debt Ratio00.07 CAD0.04 CAD
Debt-to-Equity00.08 CAD0.05 CAD
Assets / Equity1.86451.86451.8645
Cash / Equity1.42021.42021.4202
EPS-0.07 CAD-0.07 CAD-0.09 CAD
Cash Flow202420232022
Cash from operating activities-15.49 m CAD-13.65 m CAD-16.34 m CAD
Cashflow before financing6.25 m CAD-9.87 m CAD-16.62 m CAD
Increase in Cash6.24 m CAD-10.04 m CAD-16.93 m CAD
Income202420232022
Turnover2.05 m CAD1.20 m CAD638,000.00 CAD
Cost of sales728,000.00 CAD500,000.00 CAD351,000.00 CAD
Gross Profit1.32 m CAD703,000.00 CAD287,000.00 CAD
Operating Profit-19.44 m CAD-14.80 m CAD-18.76 m CAD
Pre-Tax profit-19.10 m CAD-14.41 m CAD-19.37 m CAD

Ondine Biomedical Inc. Company Background

SectorHealthcare
ActivitiesOndine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportableoperating segment that is antimicrobial photodynamic therapy (aPDT) products.
Latest Interim Date26 Sep 2025
Latest Fiscal Year End Date15 May 2025

Ondine Biomedical Inc. Directors

AppointedNamePosition
2024-05-03Mr. Craig A. ToomanNon-Executive Director
2025-09-03Ms. Carolyn CrossExecutive Director,Chief Executive Officer
2011-09-06Mr. Colin D. WattExecutive Director
2025-09-03Dr. Nicholas LoebelPresident and Chief Technology Officer
2011-09-06Mr. Michael CraneExecutive Director
2011-09-06Mr. Terry M. HollandExecutive Director
2025-09-03Ms. Margaret ShawNon-Executive Director
2010-12-21Dr. Merrill BielExecutive Director
2011-08-09Mr. Pierre LeducExecutive Director,Chairman
2025-09-03Dr. Junaid BajwaNon-Executive Director
2025-05-15The Honourable Jean CharestNon-Executive Director,Chairman
2025-09-03Ms. Jean DuvallNon-Executive Director,Senior Independent Non-Executive Director
2025-03-28Mr. Michael FarrarNon-Executive Director
2024-06-27Dr. Simon SinclairNon-Executive Director

Ondine Biomedical Inc. Contact Details

Company NameOndine Biomedical Inc
Address1100 Melville Street, Suite 888, Vancouver, V6E4A6
Telephone+1 604 669-0555
Websitehttps://www.ondinebio.com

Ondine Biomedical Inc. Advisors

AuditorErnst & Young LLP
AuditorErnst & Young Ltd.
AuditorDavidson & Company LLP
Phone+1 604 687-0947

Most Read

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
25 Sep 2025

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Ceres Power Holdings PLC371.8018.86
Metro Bank Holdings PLC118.008.26
Bluefield Solar Income Fund Limited76.906.51
Aston Martin Lagonda Global Holdings PLC61.705.65
Trainline PLC267.205.03
4Imprint Group PLC3,355.004.52

Fallers

CompanyPrice% Chg
Playtech PLC235.00-5.05
Tp Icap Group PLC251.00-4.20
Oxford Biomedica PLC660.00-3.23
Qinetiq Group PLC461.00-3.03
Victrex PLC620.00-2.97
Watches Of Switzerland Group PLC390.00-2.21
Risers/fallers data from previous trading day. Today's data available from 8:15am.